comparemela.com

Latest Breaking News On - Sartorius stedim biotech group - Page 15 : comparemela.com

Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.68 euros per share to Annual Shareholders' Meeting

Share this article Share this article AUBAGNE, France, Feb. 5, 2021 /PRNewswire/ The Board of Directors of Sartorius Stedim Biotech S.A. resolved at today s meeting to submit a proposal to the combined Annual General Shareholders Meeting on March 24, 2021, to pay a dividend for fiscal 2020 of 0.68 euros per share. Under this proposal, the total distributed profit would be €62.7 million. The previous year s dividend was 0.34 euros. This press release contains forward-looking statements about the future development of the Sartorius Stedim Biotech Group. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such statements. Sartorius Stedim Biotech assumes no liability for updating such statements in light of new information or future events. This is a translation of the original French-language press release. Sartorius Stedim Biotech shall not ass

United-states
Aubagne
Provence-alpes-côd-azur
France
French
America
Timo-lindemann
Linkedin
Sartorius-stedim-biotech-group
Corporate-communications-spokesman
Annual-general-shareholder-meeting
Sartorius-stedim-biotech

Sartorius Stedim Biotech with exceptionally strong growth in 2020 and a further increase in profitability

Sartorius Stedim Biotech with exceptionally strong growth in 2020 and a further increase in profitability USA - English - Sartorius Stedim Biotech plays a key role as a provider of essential technologies for vaccine production - Number of employees rises by 21.6 percent to more than 7,500 - Strong outlook for 2021: Sales revenue set to grow by 20 percent to 26 percent - Group management raises sales target for 2025 to 4 billion euros News provided by Share this article Share this article AUBAGNE, France, Jan. 27, 2021 /PRNewswire/ Sartorius Stedim Biotech, a leading partner of the biopharma industry, recorded exceptionally strong growth in 2020 that was driven by strong organic development, several acquisitions and additional momentum from business related to the coronavirus pandemic. According to preliminary figures, the Group closed the year with significant double-digit growth rates in sales revenue, order intake and earnings, recording further gains across all geograph

China
Germany
Puerto-rico
United-states
Aubagne
Provence-alpes-côd-azur
France
French
America
Petra-kirchhoff
Joachim-kreuzburg
Asia-pacific

Automated Cell Culture Market Statistics 2021: Showcases Promising Growth by 2027

Automated Cell Culture Market Statistics 2021: Showcases Promising Growth by 2027
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.

India
Pune
Maharashtra
Our-research-expert
Hitachi-ltd
National-institutes-of-health
Office-no
Market-research
Market-research-future
Research-newswire
See-campaign

Sartorius Stedim Biotech to acquire Novasep's chromatography process equipment division

/PRNewswire/ Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, today announced it has entered into an agreement.

China
United-states
India
Aubagne
Provence-alpes-côd-azur
France
French
America
Petra-kirchhoff
Michel-spagnol
Laure-saloin
Prnewswire-sartorius-stedim

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.